ReviewTherapeutic advances in neurological disorders2020

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.

Raed Alroughani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.